Submit your abstract

Harold Gunson Fellowships

All Young Professionals who are 40 years or younger can apply for the Harold Gunson Fellowship and receive travel, registration and accommodation for the congress.

Please make sure that you have read the Harold Gunson Fellowship Procedure carefully.

Download the application form here.

Send the completed form to: office@remove-this.isbtweb.org with the subject heading Harold Gunson Fellowship and your surname. Closing date for applications is

Closing date for applications is February 11, 2020 at 23.59 CET.

Before you send your application please make sure that you have read the Harold Gunson Fellowship Procedure carefully and that you:

  • Are 40 years or younger at the date of the first day of the congress
  • You are the first, submitting and presenting author of an abstract which has been accepted for the scientific programme

 

 

Watch the tutorial on 'How to get your abstract accepted and how to present' it by Geoff Daniels


SUBMIT AN ABSTRACT

DOWNLOAD THE ABSTRACT GUIDELINES

Abstract submission

Submission Deadline: February 11, 2020 at 23.59 CET. 

The Scientific Committee invites you to submit your scientific abstracts. Please only submit an abstract if you intend to attend the congress. Abstracts selected for oral or poster presentation will be removed from publication if the author does not register for the congress.

An international panel of experts will review and select abstracts for oral or poster presentation. The first (presenting) author will receive a confirmation of acceptance for either an oral or poster presentation, or a notice of rejection, by email by the second week of March, 2020.

ABSTRACT TOPICS

1.1 Organisational issues

1.2 Information technology

1.3 Cost/effectiveness

1.4 Training and education

1.5 Risk models, standards and regulation

1.6 Blood supply management and utilization - but not blood group or clinically related

1.7 Quality management

2.1 Blood donor recruitment and retention

2.2 Blood donor health

2.3 Blood collection including apheresis

2.4 Donor adverse events

3.1 Blood processing, storage and release
3.2 Blood components
3.3 Plasma products
3.4 Pathogen inactivation
3.5 Novel blood products

4.1 Screening strategies for TTI
4.2 Hepatitis B (HBV)
4.3 Hepatitis C (HCV)
4.4 HIV
4.5 Bacteria
4.6 Parasites
4.7 Newly emerging pathogens and other transfusion related pathogens

5.1 Red cell immunology: Serology
5.2 Red cell immunology: Molecular
5.3 Platelet immunology
5.4 Granulocyte immunology
5.5 Fetal-maternal immunology

6.1 Neonatal and pediatric transfusion

6.2 Therapeutic apheresis

6.3 Evidence based transfusion medicine practice

6.4 Haemorrhage and massive transfusion

6.5 Adverse events, including TRALI

6.6 Haemovigilance and transfusion safety

6.7 Alternatives to blood transfusion

6.8 Patient Blood Management

6.9 Transfusion practitioner related clinical practice improvement - Abstracts MUST address how the transfusion practitioner (TP ) has been involved with/or led clinical transfusion practice improvements that could relate to: Safety and appropriate use of blood and blood products, patient blood management initiatives, haemovigilance, education, activities to improve patient safety and audit.

 

 

 

7.1 Stem cell and tissue banking, including cord blood
7.2 Collection, processing, storage and release
7.3 Clinical applications

8.1 HLA in transfusion medicine
8.2 Histocompatibility in stem cell transplantation
8.3 Histocompatibility in organ transplantation

JOIN ISBT TOGETHER WE INCREASE OUR IMPACT ON TRANSFUSION MEDICINE

Quote
Quote

“ISBT provides a great opportunity to interact with colleagues worldwide and to participate in relevant discussions pertaining to the future of transfusion medicine.”

Peter Horn, Germany
Become a member of ISBT join us now